This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Røder, M. E. Articles by Kahn, S. E. Search for Related Content PubMed PubMed Citation Articles by Røder, M. E. Articles by Kahn, S. E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Seniors' Health

Reduced Pancreatic B Cell Compensation to the Insulin Resistance of Aging: Impact on Proinsulin and Insulin Levels¹

Divisions of Metabolism, Endocrinology, and Nutrition, and Gerontology and Geriatric Medicine (R.S.S.), Department of Medicine, Veterans Affairs Puget Sound Health Care System, Harborview Medical Center (R.S.S.), and University of Washington, Seattle, Washington 98108

Address all correspondence and requests for reprints to: Michael E. Røder, M.D., Department of Endocrinology F, University of Copenhagen, Hillerød Sygehus, Helsevej 2, DK-3400 Hillerød, Denmark. address: mir{at}dadlnet.dk

Type 2 diabetes mellitus is associated with insulin resistance, reduced B cell function, and an increase in the proinsulin (PI) to immunoreactive insulin (IRI) ratio (PI/IRI); the latter is thought to be an indication of B cell dysfunction. Normal aging is associated with insulin resistance and reduced B cell function, but it is not known whether changes in PI and the PI/IRI ratio are also a feature of the aging-associated B cell dysfunction. Therefore, we tested whether the aging-associated changes in insulin sensitivity and B cell function result in changes in PI and IRI levels that are proportionate or whether they are disproportionate as in type 2 diabetes.

Twenty-six healthy older (mean ± SEM age, 67 ± 1 yr) and 22 younger (28 ± 1 yr) subjects with similar body mass indexes (27.9 ± 0.6 vs. 26.3 ± 1.0 kg/m²) were studied. PI was measured by a RIA recognizing both intact PI and its conversion intermediates. The insulin sensitivity index (S_I) was quantified using the minimal model, and B cell function was measured as fasting insulin levels, the acute insulin response to glucose (AIRglucose), and as the acute insulin response to arginine at maximal glycemic potentiation (AIRmax). B cell function was also adjusted for S_I based on the known hyperbolic relationship between these two variables.

Older and younger subjects had similar fasting glucose (5.3 ± 0.1 vs. 5.2 ± 0.1 mmol/L), IRI (83 ± 8 vs. 76 ± 9 pmol/L), PI (8.9 ± 0.8 vs. 10.6 ± 2.0 pmol/L), and PI/IRI ratio (12.3 ± 1.3% vs. 13.9 ± 1.6%; all P = NS) despite a 50% reduction of insulin sensitivity (S_I, 1.94 ± 0.21 vs. 3.88 ± 0.38 x 10^-5 min^-1/pmol·L; P < 0.001) and in B cell function [S_I x fasting IRI, 139 ± 18 vs. 244 ± 24 x 10^-5 (P < 0.001); S_I x AIRglucose, 0.75 ± 0.13 vs. 1.70 ± 0.15 x 10^-2 min^-1 (P < 0.001); S_I x AIRmax, 3.63 ± 0.53 vs. 6.81 ± 0.70 x 10^-2 min^-1 (P < 0.001)] in the older subjects.

These findings suggest that the B cell dysfunction in older subjects is not associated with disproportionate proinsulinemia. However, in older subjects the B cell response to the insulin resistance of aging is reduced whether measured as fasting levels of PI or IRI or as the acute response to secretagogues. Thus, when examined in terms of the degree of insulin sensitivity, the lower fasting IRI levels in older subjects suggest that the utility of fasting insulin levels as a surrogate measure of insulin resistance in older individuals may be limited.

This article has been cited by other articles:

				J. M. Burns, J. E. Donnelly, H. S. Anderson, M. S. Mayo, L. Spencer-Gardner, G. Thomas, B. B. Cronk, Z. Haddad, D. Klima, D. Hansen, et al. Peripheral insulin and brain structure in early Alzheimer disease Neurology, September 11, 2007; 69(11): 1094 - 1104. [Abstract] [Full Text] [PDF]

				S. R. Gambert and S. Pinkstaff Emerging Epidemic: Diabetes in Older Adults: Demography, Economic Impact, and Pathophysiology Diabetes Spectr, October 1, 2006; 19(4): 221 - 228. [Abstract] [Full Text] [PDF]

				K. Maedler, D. M. Schumann, F. Schulthess, J. Oberholzer, D. Bosco, T. Berney, and M. Y. Donath Aging Correlates With Decreased {beta}-Cell Proliferative Capacity and Enhanced Sensitivity to Apoptosis: A Potential Role for Fas and Pancreatic Duodenal Homeobox-1 Diabetes, September 1, 2006; 55(9): 2455 - 2462. [Abstract] [Full Text] [PDF]

				A. Alonso, R. Fernandez, M. Moreno, P. Ordonez, H. Gonzalez-Pardo, N. M. Conejo, F. Diaz, and C. Gonzalez Positive Effects of 17{beta}-Estradiol on Insulin Sensitivity in Aged Ovariectomized Female Rats. J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2006; 61(5): 419 - 426. [Abstract] [Full Text] [PDF]

				S. A. Smith, L. E. Porter, N. Biswas, and M. I. Freed Rosiglitazone, But Not Glyburide, Reduces Circulating Proinsulin and the Proinsulin:Insulin Ratio in Type 2 Diabetes J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6048 - 6053. [Abstract] [Full Text] [PDF]

				M. E. Roder and S. E. Kahn Suppression of Beta-Cell Secretion by Somatostatin Does Not Fully Reverse the Disproportionate Proinsulinemia of Type 2 Diabetes Diabetes, December 1, 2004; 53(suppl_3): S22 - S25. [Abstract] [Full Text] [PDF]

				K. M. Utzschneider, D. B. Carr, R. L. Hull, K. Kodama, J. B. Shofer, B. M. Retzlaff, R. H. Knopp, and S. E. Kahn Impact of Intra-Abdominal Fat and Age on Insulin Sensitivity and {beta}-Cell Function Diabetes, November 1, 2004; 53(11): 2867 - 2872. [Abstract] [Full Text] [PDF]

				K. M. Utzschneider, D. B. Carr, S. M. Barsness, S. E. Kahn, and R. S. Schwartz Diet-Induced Weight Loss Is Associated with an Improvement in {beta}-Cell Function in Older Men J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2704 - 2710. [Abstract] [Full Text] [PDF]

				F. Bacha, R. Saad, N. Gungor, and S. A. Arslanian Adiponectin in Youth: Response to Stefan et al. Diabetes Care, June 1, 2004; 27(6): 1520 - 1521. [Full Text]

				N. Stefan, M. Stumvoll, H.-U. Haring, and A. Fritsche Adiponectin in Youth: Response to Bacha et al. Diabetes Care, June 1, 2004; 27(6): 1519 - 1520. [Full Text]

				M. E. Doyle and J. M. Egan Pharmacological Agents That Directly Modulate Insulin Secretion Pharmacol. Rev., March 1, 2003; 55(1): 105 - 131. [Abstract] [Full Text] [PDF]

				A. M. Chang and J. B. Halter Aging and insulin secretion Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E7 - E12. [Abstract] [Full Text] [PDF]

				A. Fritsche, A. Madaus, N. Stefan, O. Tschritter, E. Maerker, A. Teigeler, H. Haring, and M. Stumvoll Relationships Among Age, Proinsulin Conversion, and {beta}-Cell Function in Nondiabetic Humans Diabetes, February 1, 2002; 51(90001): S234 - 239. [Abstract] [Full Text] [PDF]